Nearly one in four U.S. households reports using a GLP-1 medication, and projections suggest that figure could rise to 35 percent by 2030. However, new research shows many users may ...
MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that ...
The study found that counties located closer to nuclear power plants experienced higher cancer mortality rates.
A new study developed and launched by the Foundation for the National Institutes of Health’s Biomarkers Consortium shows that a single blood test can assess not only a person’s risk of developing ...
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results